Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial.
JAMA Neurol. 2023 Jul 1;80(7):682-692. doi: 10.1001/jamaneurol.2023.1526.
JAMA Neurol. 2023.
PMID: 37222252
Free PMC article.
Clinical Trial.
Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850).
Bath PM, Mhlanga I, Woodhouse LJ, Doubal F, Oatey K, Montgomery AA, Wardlaw JM; LACI-2 Trial Investigators.
Bath PM, et al.
Stroke Vasc Neurol. 2023 Apr;8(2):134-143. doi: 10.1136/svn-2022-001816. Epub 2022 Sep 2.
Stroke Vasc Neurol. 2023.
PMID: 36219567
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite